WHO ICTRP trial
Study of safety and tolerability of MIW815 (ADU-S100) in combination with
JPRN-jRCT2080223739 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080223739 |
|---|---|
| Public title | Study of safety and tolerability of MIW815 (ADU-S100) in combination with |
| Scientific title | A phase 1b, open label, multicenter study of the safety and efficacy of MIW815(ADU-S100) administered by intratumoral injection with PDR001 to patients with advanced/metastatic solid tumors or lymphomas |
| Primary sponsor | Novartis K K |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Countries | Japan;Asia except Japan;North America;South America;Europe;Oceania |
| Conditions | Advanced/metastatic solid tumors or lymphomas |
| Interventions | investigational material(s) Generic name etc : MIW815(ADU-S100) INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : The first dose escalation… |
| Registration date | May 12, 2017 |
| Target size | 9 |
| Secondary IDs | NCT03172936;JapicCTI-173795 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: